Handbook of Biologics for Rheumatological Disorders

About this book
Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics,necessitates immediate evaluation  of individual biologic  agents and their best use in the new treatment regimens.

This book provides an inclusive approach with the existing evidence concerning effectiveness and implications on the usage of biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of these agents in varied autoimmune diseases. This manual also offers a complete overview of the existing & futuristic biologic treatments, and draws recommendations on how to standardize the most suitable regimen for a specific patient in the context of current guidelines. The handbook of Biologics in Rheumatology serves as a present and concise compendium to the modern therapeutic developments in the field.
This book is likely to benefit  clinicians, residents, fellow and other healthcare workers dealing with rheumatological disorders, and also hard-core Rheumatologists, who are looking for a quick recap of Biologics of their interest

Table of contents (27 chapters)


    Front Matter
    Pages i-x
    PDF
    A Historical Introduction to the Biological Response Modifier Drugs: The ‘Biologicals’
        Anand N. Malaviya
    Pages 1-11
    Biologics in Rheumatoid Arthritis
        Rohini Handa
    Pages 13-21
    Biologics in Spondyloarthritis
        Bimlesh Dhar Pandey
    Pages 23-30
    Biologics in Psoriatic Arthritis
        Rahul Sahu, Arvind Ganapati, Ashish Jacob Mathew
    Pages 31-53
    Biologics in Gout
        Abhishek
    Pages 55-60
    Biologics in Systemic Lupus Erythematosus (SLE)
        Chi Chiu Mok
    Pages 61-73
    Biologics in Sjogren’s Syndrome
        Elizabeth Price
    Pages 75-84
    Biologics in Systemic Sclerosis
        David Roofeh, Alain Lescoat, Dinesh Khanna
    Pages 85-99
    Biologics in Idiopathic Inflammatory Myopathies
        Rudra Prosad Goswami, Uma Kumar
    Pages 101-112
    Biologics in ANCA-Associated Vasculitides
        Saket Jha, Aman Sharma
    Pages 113-120
    Biologics in Behcet’s syndrome
        Rudrarpan Chatterjee, Sundeep Grover, Vikas Agarwal
    Pages 121-125
    Biologics in Takayasu’s Arteritis
        Avanish Jha, Debashish Danda
    Pages 127-140
    Biologics in Interstitial Lung Diseases in Rheumatological Disorders
        Ashish Sharma, Ashok Kumar
    Pages 141-146
    Biologics in Osteoporosis
        Ira Pande
    Pages 147-156
    Biologics in Osteoarthritis
        Siddharth Kumar Das
    Pages 157-164
    Biologics in Juvenile Idiopathic Arthritis
        Mehul P. Jariwala, Sujata Sawhney
    Pages 165-178
    Biologics in Pediatric Connective Tissue Disorders
        Sarit Sekhar Pattanaik, Amita Aggarwal
    Pages 179-185
    JAK Inhibitors in Rheumatic Disease
        P. D. Rath, S. S. Nelson, A. K. Khan
    Pages 187-197
    Biologics in Rheumatic Diseases in the Presence of Infection
        Padmanabha Shenoy, Kaveri K. Nalianda
    Pages 199-212


    Biologics in Rheumatologic Conditions with Malignancy
        Lata Bichile, Dipti Patel, Tanmayee Bichile
    Pages 213-223
    Biologics in Uveitis
        Sirichai Pasadhika, James T. Rosenbaum
    Pages 225-235
    Biologics in Sarcoidosis
        Ved Chaturvedi, Mayank Gupta
    Pages 237-241
    Biologics in IgG4-Related Disease
        Amit Dua, Neeraj Jain, Lalit Duggal, Bhavya Chintala
    Pages 243-252
    Biosimilars in Rheumatology
        Mohit Goyal, Vinod Ravindran
    Pages 253-260
    Off-Label Use of Biologics in Rheumatological Disorders
        Sumantro Mondal, Alakendu Ghosh
    Pages 261-272
    Biologics and Ethical Issues in Rheumatology
        Nibha Jain, Dhaiwat Shukla, Prashant Chotalia, Sapan C. Pandya
    Pages 273-282
    Patient Consent for Biologics
        S. J. Gupta
    Pages 283-288